Quarterly report pursuant to Section 13 or 15(d)

Nature of Operations, Basis of Presentation and Liquidity (Details)

v3.20.2
Nature of Operations, Basis of Presentation and Liquidity (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Nature of Operations, Basis of Presentation and Liquidity (Textual)            
Net loss $ (815) $ (921) $ (2,452) $ (3,071)    
Net revenues     56 100    
Accumulated deficit (41,777)   (41,777)   $ (39,325)  
Cash 791 $ 396 791 396 64 $ 15
Working capital 1,459   1,459      
Current assets 2,313   2,313   1,758  
Current liabilities 854   854   $ 1,712  
Net cash used in/provided by operating activities     $ (2,211) (1,904)    
Ownership of shares, description     Under the exchange ratio formula in the Merger Agreement, as of immediately after the Merger, the former MedAvail security holders are expected to own approximately 96.5% of the aggregate number of fully-diluted shares of MYOS Common Stock outstanding following the consummation of the Merger (the "Post-Closing Shares"), and the stockholders of MYOS immediately prior to the Merger are expected to own approximately 3.5% of the Post-Closing Shares, subject to the adjustments set forth in the Merger Agreement.      
Myos [Member]            
Nature of Operations, Basis of Presentation and Liquidity (Textual)            
Cash 2,000   $ 2,000      
Termination fee payable     750,000      
Promissory note $ 3,000   3,000      
MedAvail, Inc. [Member]            
Nature of Operations, Basis of Presentation and Liquidity (Textual)            
Termination fee payable     500,000      
YOLKED [Member]            
Nature of Operations, Basis of Presentation and Liquidity (Textual)            
Net revenues     176 229    
Myos Canine Muscle Formula [Member]            
Nature of Operations, Basis of Presentation and Liquidity (Textual)            
Net revenues     853 282    
Physician Muscle Health Formula [Member]            
Nature of Operations, Basis of Presentation and Liquidity (Textual)            
Net revenues     $ 19 $ 42